Andela, Valentine B <br/><br/>
The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids.  [electronic resource] 

 -  Molecular cancer  Mar 2004 
 - 8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-3-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Active Transport, Cell Nucleus--physiology<br/>Cell Line, Tumor<br/>Cell Nucleus--metabolism<br/>DNA, Neoplasm--metabolism<br/>DNA-Binding Proteins--antagonists & inhibitors<br/>Enzyme Activation--physiology<br/>Gene Expression Regulation--physiology<br/>Humans<br/>Leupeptins--pharmacology<br/>Ligands<br/>Macromolecular Substances--antagonists & inhibitors<br/>Matrix Metalloproteinase 9--metabolism<br/>NF-kappa B--genetics<br/>Neoplasm Metastasis--pathology<br/>Neoplasm Proteins<br/>Protein Transport--physiology<br/>Receptors, Retinoic Acid--antagonists & inhibitors<br/>Repressor Proteins--physiology<br/>Retinoids<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Transcriptional Activation--drug effects